Retina Synthesis
by Retina SynthesisRetina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.
Copyright: © 2024 Retina Synthesis
Episodes
NSAIDS in the treatment of Central Serous Chorioretinopathy
14m · PublishedWe discuss the use of non steroidal inflammatory agents in the management of central serous chorioretinopathy with Dr. Michael Singer of San Antonio, Texas
EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
21m · PublishedWe discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.
Intravitreal Gene Therapy for neovascular AMD with 4D-150
13m · PublishedWe discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.
KSI 501 Bispecific Anti-VEGF Biopolymer Treatment of DME
7m · PublishedWe discuss the use of a novel bispecific anti-VEGF Anti IL-6 Antibody Biopolymar Conjugate for the treatment of DME with Dr. Mark R. Barakat of Phoenix, AZ.
Retinal Vasculitis Following Pegcetcoplan Therapy of Geographic Atrophy
15m · PublishedWe discuss the occurrence of retinal vasculitis following pegcetcoplan therapy of geographic atrophy with Dr. Andrew Witkin of the New England Eye Center, Tufts University School of Medicine
High Dose Aflibercept in Severe Diabetic Macular Edema
12m · PublishedWe discuss the treatment results of high dose aflibercept in the eyes in the most severe quartile of diabetic macular edema with Dr. Roger Goldberg of Walnut Creek, California.
IL-6 Inhibition in the Treatment of Uveitis Macular Edema
9m · PublishedWe discuss the use of an IL-6 inhibitor in the treatment of uveitis macular edema with Dr. Sumit Sharma of the Cole Eye Institute, Cleveland Clinic.
The High Dose Aflibercept DME Trial
18m · PublishedWe discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
The Annexon Geographic Atrophy Trial
11m · PublishedWe discuss the unique results of the Annexon geographic atrophy Phase I clinical trial with Dr. Roger Goldberg of Bay Area Retina Associates, Walnut Creek, California
Diagnostics for Retinoblastoma
19m · PublishedWe review the latest diagnostic and therapeutic approaches for retinoblastoma with Dr. Jesse Berry, Associate Professor of Ophthalmology, Children's Hospital Los Angeles.
Retina Synthesis has 143 episodes in total of non- explicit content. Total playtime is 39:36:04. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on May 3rd, 2024 06:11.